Effectively Navigate the Rapidly Evolving Pharmacy Market
As a pharmaceutical consulting company, Archbow helps biopharma manufacturers develop dispensing strategies that navigate the rapidly evolving specialty pharmacy market. Our 360-degree approach includes a customized mix of strategic and tactical actions, such as:
-
- Pharmacy network design
- Biopharma market landscape assessments, including industry trends, competitive intelligence, analog research, real-world benchmarking, and market research
- Operations and technology assessments for pharmacy programs
- Pharmaceutical Fair Market Value assessments
- Cost modeling for pharmacy programs
- Biosimilar strategies
- Specialty Pharmacy RFP management and vendor selection
- Contract review and negotiation
- Program implementation
- Data definitions, analysis, and insights
- Pharmacy program performance monitoring and analysis
Learn more about our pharmacy team and the differentiators that matter most to manufacturers, and contact us today for assistance with your strategic and tactical pharmacy needs.
You can also learn more about Best Practices for Improving SP Program Performance and read our Health System Specialty Pharmacy Trend Report.
For additional insights on this topic, you may also enjoy the following case studies:
For additional insights on this topic, you may also enjoy the following blog posts:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
FDA Extends Compliance Deadline for Updated DSCSA Requirements
Understanding the revised timeline for compliance with specific updated DSCSA requirements
Are Direct-to-Patient Access Models the Future of Pharma?
Understanding the opportunity to sell directly to patients via a cash model
Key Takeaways from NASP 2024
The 2024 National Association of Specialty Pharmacy (NASP) conference showcased a landscape of rapid innovation and evolving industry trends.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|